Rekombinanter LIV-1 (Ladiratuzumab Biosimilar) Antikörper
Research Grade
Reaktivität: Human
ELISA
Wirt: Humanized
Monoclonal
unconjugated
Recombinant Antibody
1 image
-
- Target
- LIV-1 (Ladiratuzumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
- Wirt
-
Humanized
- Klonalität
- Monoklonal
- Applikation
- ELISA
- Verwendungszweck
- Anti-LIV-1 (ladiratuzumab biosimilar) mAb
- Produktmerkmale
- hLIV22
- Aufreinigung
- Purified from cell culture supernatant by affinity chromatography
- Güteklasse
- Research Grade
- Isotyp
- IgG1
-
- Applikationshinweise
- ELISA 1:5000-10000
- Kommentare
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute with deionized water
- Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- Haltbarkeit
- 12 months
-
- Target
- LIV-1 (Ladiratuzumab Biosimilar)
- Substanzklasse
- Biosimilar
- Hintergrund
- Synonyms: LIV1, SLC39A6, ZIP-6
- UniProt
- Q13433
-
Sie sind hier:
